Baltimore venue’s close proximity to FDA reflected in agenda’s focus on regulatory topics
<0> For PHT CorporationBrenda Nashawaty, 617-688-3253 </0>
Early registrations have begun from clinical research professionals for the 9 being held March 26-28, 2013, in Baltimore, Maryland. The Congress is hosted by , the leading provider of innovative technology systems used to collect for clinical research.
Participants at the exclusive two-day meeting gain expertise in the scientific, technical and regulatory requirements of patient reported outcomes and electronic clinical outcome assessments. Educational sessions are based on best practices and lessons learned, providing practical and actionable information for attendees to bring back to their organizations.
The Congress is organized for professionals in Clinical Operations, Outsourcing, Data Management, eClinical Technologies, Regulatory Affairs, and Health Outcomes. Participants voiced unanimous approval of the last PRO & eCOA Congress held in France this year:
Sheila Rocchio, PHT Vice President of Marketing and Product Management, said, “The Congress provides a unique opportunity for attendees across the industry to share ideas, strategies, experiences and lessons learned with their peers in a collegial setting. We share the same goal of improving clinical development by putting patients and patient-driven eData at the center of research.”
Regardless of their experience with PRO, attendees will discover how clinical, data management, regulatory and outsourcing functional groups work collaboratively with PRO data. They learn how to become internal leaders in PRO and eCOA – helping teams assess their eClinical data needs, expediting study set-up times, and reducing time monitoring and analyzing data. Agenda highlights include a demonstration of new PRO mobile apps and technology slated for release early next year.
The venue’s close proximity to FDA is reflected in the agenda which includes a focus on regulatory topics.
2013 PRO & eCOA Congress topics will include:
To register for the 2013 PRO & eCOA Congress visit
PHT President and CEO Philip Lee commented, “This year there is an even greater demand among sponsors and CROs to learn how to leverage PRO and eCOA technologies as a strategic asset.” Watch Phil’s take on the top 5 reasons for the growth of ePRO/eCOA in clinical research
PHT invites all Congress alumni to join the exclusive to continue the conversation by exchanging information, ideas and experiences.
PHT Corporation helps pharmaceutical companies and CROs conduct clinical studies with greater confidence, ease and accuracy. We enable our clients to gain insights, through measuring how patients feel and function, that help speed therapies to market and improve lives. From our 550+ global trial experiences including 16 regulatory approvals, we offer the breadth, history and scientific expertise today’s market demands. PHT's proven Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via PHT’s StudyWorks® online portal, provides sponsors and clinicians with a real-time window to patients between visits for improved protocol compliance and safety monitoring. For more information on Patient Driven eData, eCOA and ePRO, review the interactive content and demonstrations at . Follow PHT on @PHT ePRO.